Delivery Order SPE2DB20D2002-SPE2DB22FK98D
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of BROMSITE 0.075% eye drops. The $4,112.11 firm-fixed-price contract has a completion date of November 30, 2021 and was awarded on November 29, 2021. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains several Indefinite Delivery Contracts (IDCs) with the DLA and the...
- The Defense Logistics Agency (DLA) awarded a $3,496.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The contract is for the supply of Bromsite 0.075% eye drops, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The contract, valued at $3,547.25, is a firm fixed-price delivery order with a completion date of December 11, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award with a ceiling value of $4,421.74 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for the supply of BROMSITE 0.075% eye drops in 5 milliliter bottles, to be delivered by March 16, 2023. This contract is not associated with any set-aside requirements. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The $6,604.74 firm fixed-price delivery order has a completion date of November 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,615.05 for the supply of 4556120380 - BROMSITE 0.075% EYE DROPS 5ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 2, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BROMSITE 0.075% eye drops in 5mL bottles, with a ceiling value of $7,789.71 and a completion date of August 17, 2023. The contract has a firm fixed price pricing type and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,498.63 fixed-price delivery order is for the supply of BROMSITE 0.075% eye drops, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award, valued at $6,581.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of Bromsite 0.075% eye drops, a specialty medication, to support military and government healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the procurement of BROMSITE 0.075% eye drops, with a ceiling value of $4,466.70. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FK98DDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,699.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., for the procurement of BROMSITE 0.075% eye drops. This award was not designated as a set-aside contract. Amerisourcebergen Drug Corp. is a major pharmaceutical distributor that provides a wide range of medical products and supplies to various federal agencies, including the Department of Defense and Department of Veterans Affairs. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for delivering pharmaceutical products and medical commodities to support military healthcare programs globally. This specific delivery order contract covers the supply of the prescription eye medication BROMSITE 0.075% in 5ml vials, with a performance period ending on October 28, 2021. As a prime contractor, Amerisourcebergen Drug Corp. is responsible for fulfilling this requirement, which aligns with the DLA's mission of providing medical supplies and pharmaceuticals to military treatment facilities and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/27/21 |